Evidence map›Paper›PMID 37812242›Full record

Observational studyIntensive care medicine2023

European Network for ICU-Related Respiratory Infections (ENIRRIs): a multinational, prospective, cohort study of nosocomial LRTI.

Ignacio Martin-Loeches, Luis Felipe Reyes, Saad Nseir, Otavio Ranzani, Pedro Povoa, Emili Diaz, Marcus J Schultz, Alejandro H Rodríguez, Cristian C Serrano-Mayorga, Gennaro De Pascale and 28 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Intensive care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Antimicrobial Resistance and Virulence ofAntibiotics (Basel, Switzerland) · 2026
    Article
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Challenges and opportunities in the management of severe pneumonia. Key concepts from the Seventh Annual Meeting of Spanish Experts 2025.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Review
  10. Article
  11. Article
  12. Monosodium Glutamate InhibitsMicroorganisms · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 20 institutions in 15 countries.

Ignacio Martin-Loeches *St James's University Hospital, Trinity College, Dublin 8, D08 NHY, Ireland. drmartinloeches@gmail.com.ORCID 0000-0002-5834-4063
Luis Felipe Reyes *Unisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chia, Colombia.
Saad NseirUniversity Hospital of Lille, Lille, France.
Otavio RanzaniHospital Clinic of Barcelona, Barcelona, Spain.
Pedro PovoaHospital de Sao Francisco Xavier, Lisbon, Portugal.
Emili DiazCorporacio Sanitaria Parc Tauli, Sabadell, Spain.
Marcus J SchultzAcademic Medical Center, Amsterdam, The Netherlands.
Alejandro H RodríguezHospital Joan XXIII de Tarragona, Tarragona, Spain.
Cristian C Serrano-MayorgaUnisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chia, Colombia.
Gennaro De PascaleDepartment of Intensive Care Policlinico Gemelli, Rome, Italy.
Paolo NavalesiMagna Graecia University, Catanzaro, Italy.
Mauro PanigadaAnesthesia and Critical Care, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Luis Miguel CoelhoHospital de Sao Francisco Xavier, Lisbon, Portugal.
Szymon SkoczynskiMedical University of Silesia, Katowice, Poland.
Mariano EsperattiHospital Privado de Comunidad, Mar del Plata, Argentina.
Andrea CortegianiPoliclinico Paolo Giaccone, University of Palermo, Palermo, Italy.
Stefano AlibertiMedical University of Silesia, Katowice, Poland.
Anselmo CaricatoSant'Andrea (ASL VC), Vercelli, Italy.
Helmut J F SalzerDepartment of Internal Medicine 4-Pneumology, Kepler University Hospital, Linz, Austria.
Adrian CeccatoHospital Clinic of Barcelona, Barcelona, Spain.
Rok Civljak"Dr. Fran Mihaljevic" University Hospital for Infectious Diseases, Zagreb, Croatia.
Paolo Maurizio SoaveDepartment of Surgical Intensive Care Policlinico Gemelli, Rome, Italy.
Charles-Edouard LuytGroupe Hospitalier Pitie-Salpitriere, Paris, France.
Pervin Korkmaz EkrenEge University Medical Faculty, Izmir, Turkey.
Fernando RiosHospital Nacional Alejandro Posadas, Buenos Aires, Argentina.
Joan Ramon MasclansHospital del Mar, Barcelona, Spain.
Judith MarinIntensive Care Medicine, Hospital del Mar & IMIM, Barcelona, Spain.
Silvia Iglesias-MolesHospital Arnau de Vilanova de Lleida, Lleida, Spain.
Stefano NavaS. Orsola-Malpighi Hospital, Bologna, Italy.
Davide ChiumelloASST Santi Paolo e Carlo, Milan, Italy.
Lieuwe D BosAcademic Medical Center, Amsterdam, The Netherlands.
Antoni ArtigasCorporacio Sanitaria Parc Tauli, Sabadell, Spain.
Filipe FroesHospital Pulido Valente, Lisbon, Portugal.
David GrimaldiHospital Erasme Universit Libre de Bruxelles, Brussels, Belgium.
Fabio Silvio TacconeHospital Erasme Universit Libre de Bruxelles, Brussels, Belgium.
Massimo AntonelliDepartment of Intensive Care Policlinico Gemelli, Rome, Italy.
Antoni TorresHospital Clinic of Barcelona, Barcelona, Spain. ATORRES@clinic.cat.
European Network for ICU-Related Respiratory Infections (ENIRRIs) European Respiratory Society-Clinical Research Collaboration Investigators
Agostino Gemelli University Polyclinic · ITHospital Clínic de Barcelona · ESAzienda Ospedaliera Sant'Andrea · ITCorporació Sanitària Parc Taulí · ESHospital of St. Francis Xavier · PTUniversidad de La Sabana · COUniversité Libre de Bruxelles · BEAmsterdam UMC Location University of Amsterdam · NLAzienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo · ITAzienda Socio Sanitaria Territoriale Santi Paolo e CarloEge University · TRFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITHospital Arnau de Vilanova · ESHospital Posadas · ARHospital Privado de Comunidad · ARHospital Pulido Valente · PTHospital Universitari Joan XXIII de Tarragona · ESHumanitas University · ITIntensive Care Foundation · AUIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · IT

Funding

Universidad de La Sabana MED-244-2018
6 · The paper itself

Abstract

purposeLower respiratory tract infections (LRTI) are the most frequent infectious complication in patients admitted to the intensive care unit (ICU). We aim to report the clinical characteristics of ICU-admitted patients due to nosocomial LRTI and to describe their microbiology and clinical outcomes.

methodsA prospective observational study was conducted in 13 countries over two continents from 9th May 2016 until 16th August 2019. Characteristics and outcomes of ventilator-associated pneumonia (VAP), ventilator-associated tracheobronchitis (VAT), ICU hospital-acquired pneumonia (ICU-HAP), HAP that required invasive ventilation (VHAP), and HAP in patients transferred to the ICU without invasive mechanical ventilation were collected. The clinical diagnosis and treatments were per clinical practice and not per protocol. Descriptive statistics were used to compare the study groups.

results1060 patients with LRTI (72.5% male sex, median age 64 [50-74] years) were included in the study; 160 (15.1%) developed VAT, 556 (52.5%) VAP, 98 (9.2%) ICU-HAP, 152 (14.3%) HAP, and 94 (8.9%) VHAP. Patients with VHAP had higher serum procalcitonin (PCT) and Sequential Organ Failure Assessment (SOFA) scores. Patients with VAP or VHAP developed acute kidney injury, acute respiratory distress syndrome, multiple organ failure, or septic shock more often. One thousand eight patients had microbiological samples, and 711 (70.5%) had etiological microbiology identified. The most common microorganisms were Pseudomonas aeruginosa (18.4%) and Klebsiella spp (14.4%). In 382 patients (36%), the causative pathogen shows some antimicrobial resistance pattern. ICU, hospital and 28-day mortality were 30.8%, 37.5% and 27.5%, respectively. Patients with VHAP had the highest ICU, in-hospital and 28-day mortality rates.

conclusionVHAP patients presented the highest mortality among those admitted to the ICU. Multidrug-resistant pathogens frequently cause nosocomial LRTI in this multinational cohort study.

Indexed as

Cross InfectionPneumonia, Ventilator-AssociatedRespiratory Tract InfectionsCohort StudiesFemaleHospitalsHumansIntensive Care UnitsMaleMiddle AgedProspective StudiesSepsis ICUVA-LRTIVAPVAT

Identifiers

PMID37812242
PMCPMC10562498
OpenAlexW4387440229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.